These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Cao X, He N, Sun J, Tan J, Zhang C, Yang J, Lu T, Li J. Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513 [Abstract] [Full Text] [Related]
3. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma]. Antoch G, Mueller SP, Hamami M, Heusner TA, Ertle J, Hilgard P, Forsting M, Bockisch A. Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369 [Abstract] [Full Text] [Related]
13. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):13-23. PubMed ID: 17448867 [Abstract] [Full Text] [Related]
18. Intrahepatic (90)Y-microspheres for hepatocellular carcinoma. Ho S, Lau JW, Leung TW. J Nucl Med; 2001 Oct 01; 42(10):1587-9. PubMed ID: 11585877 [No Abstract] [Full Text] [Related]
19. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma. Allison C. Issues Emerg Health Technol; 2007 Sep 01; (102):1-6. PubMed ID: 17824141 [Abstract] [Full Text] [Related]